An innovative vaccine development company based on the frontier technology of immunology
Location: China
Investors 2
Date | Name | Website |
- | New Allian... | nac-capita... |
09.02.2022 | Matrix Par... | matrixpart... |
Mentions in press and media 1
Date | Title | Description | Source |
04.06.2021 | Advaccine Announces First Participants Dosed in Phase 2 Stud... | SUZHOU, China, June 4, 2021 /PRNewswire/ -- Advaccine Biopharmaceuticals ("Advaccine") ann... | en.prnasia... |